What is Johnson Pharmacare share price return in the past 10 years?

Johnson Pharmacare Ltd share price has declined -19.3% annually (CAGR) over the past ten years.

Johnson Pharmacare Ltd - Stock Valuation and Financial Performance

Name: Johnson Pharmacare
Brand: Johnson Pharmacare

BSE: 532154 | NSE: | Trading | Small Cap

Place order

Johnson Pharmacare Share Price

₹0.79 -0.01 -1.25%
as on 19-Apr'24 16:01

DeciZen - make an informed investing decision on Johnson Pharmacare

Based on:

Data

M-Cap below 100cr DeciZen not available

Johnson Pharmacare stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

44 Cr.

52-wk low:

0.5

52-wk high:

1.4

Is Johnson Pharmacare Ltd an attractive stock to invest in?

1. Is Johnson Pharmacare Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Johnson Pharmacare Ltd is a below average quality company.

2. Is Johnson Pharmacare Ltd undervalued or overvalued?

The key valuation ratios of Johnson Pharmacare Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Johnson Pharmacare Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Johnson Pharmacare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Johnson Pharmacare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	-0.1%	-0.1%	-0.2%	-0.1%	-0.1%	-0%	-0.2%	0%	0.2%	-0.4%	-
Value Creation Index ⓘ	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0	NA	-1.0	-1.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	1,791	0	0	0	0	0.9	0	0.8	3.3	2.5	0
Sales YoY Gr.	-	-100%	NA	NA	NA	NA	-100%	NA	329%	-22.4%	-
Adj EPS ⓘ	0	0	0	0	0	0	0	0	0	0	-0
YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	1.1	1.1	1.1	1.1	1.1	1.1	1.1	1.1	1	1	1
Adj Net Profit ⓘ	-0.1	-0.1	-0.1	-0.1	-0.1	0	-0.1	0	0.1	-0.2	-1
Cash Flow from Ops. ⓘ	3.9	8.3	-10.9	10.7	-0.9	-0.9	0.2	-0.1	4.9	-0.4	-
Debt/CF from Ops. ⓘ	0.3	0.1	-0.1	0.1	-2	-1.8	3.7	-6.4	0.1	-4.8	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-51.8%	NA	NA	-22.4%
Adj EPS ⓘ	NA	NA	NA	NA
BVPSⓘ	-0.2%	-0.4%	-0.6%	8.3%
Share Price	-19.3%	-22.4%	46.7%	41.1%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	-0.1	-0.1	-0.2	-0.1	-0.1	-0	-0.2	0	0.2	-0.4	-1
Op. Profit Mgn % ⓘ	0	0	0	0	0	-1.2	0	0.2	4.1	8.8	NAN
Net Profit Mgn % ⓘ	0	0	0	0	0	-1.2	0	0.2	3	-8.1	-INF
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	4	0	0	0	0	2,393	0	3,175	713	1,447	0
Cash Conv. Cycle ⓘ	2	0	0	0	0	183	0	448	110	76	0

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at -25.00%

Latest Financials - Johnson Pharmacare Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-0	-
TTM Sales (₹ Cr.)	0	-
BVPS (₹.) ⓘ	1	-
Reserves (₹ Cr.) ⓘ	2	-
P/BV ⓘ	0.78	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.45 / 1.38
All Time Low / High (₹)	0.11 / 21.02
Market Cap (₹ Cr.)	44
Equity (₹ Cr.)	55
Face Value (₹)	1
Industry PE ⓘ	75.8

Management X-Ray of Johnson Pharmacare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Johnson Pharmacare

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Johnson Pharmacare

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	1,791.02	0	0	0	0	0.92	0	0.76	3.26	2.53
Operating Expenses ⓘ	1,791.10	0.07	0.13	0.08	0.06	0.93	0.09	0.76	3.13	3.86
Manufacturing Costs	0	0	0	0	0	0	0	0	0	0
Material Costs	1,790.94	0	0	0	0	0.90	0	0.65	2.69	2.02
Employee Cost	0	0	0.01	0.03	0.03	0.02	0.02	0.02	0.10	0.07
Other Costs ⓘ	0.15	0.07	0.11	0.05	0.03	0.01	0.07	0.08	0.34	1.76
Operating Profit ⓘ	-0.08	-0.07	-0.13	-0.08	-0.06	-0.01	-0.09	0	0.13	-1.33
Operating Profit Margin (%)	0.0%	-	-	-	-	-1.2%	-	0.2%	4.1%	-52.6%
Other Income ⓘ	0	0	0	0.05	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0	0	0
Depreciation ⓘ	0.01	0	0	0	0	0	0	0	0	0
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	-0.08	-0.07	-0.13	-0.03	-0.06	-0.01	-0.09	0	0.13	-1.33
Tax ⓘ	0	0	0	0.04	0	0	0	0	0.04	-0.04
Profit After Tax	-0.08	-0.07	-0.13	-0.08	-0.06	-0.01	-0.09	0	0.10	-1.29
PAT Margin (%)	0.0%	-	-	-	-	-1.2%	-	0.2%	3.0%	-51.1%
Adjusted EPS (₹)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	58.56	58.49	58.36	58.29	58.23	58.21	58.14	58.14	58.24	56.95
Share Capital ⓘ	50	50	50	50	50	50	50	50	55	55
Reserves ⓘ	8.56	8.49	8.36	8.29	8.23	8.21	8.14	8.14	3.24	1.95
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	1.11	0.61	0.61	0.61	1.69	1.69	0.63	0.69	0.61	1.91
Long Term Debt	0.61	0.61	0.61	0.61	1.69	1.69	0.63	0.69	0.61	1.91
Short Term Debt	0.50	0	0	0	0	0	0	0	0	0
Trade Payables	0.43	0.42	0	0	0	0	0	0.65	0	0
Others Liabilities ⓘ	0.02	0.02	0.07	0.08	0.02	0.02	0	0	1.13	0.98
Total Liabilities ⓘ	60.12	59.54	59.03	58.97	59.94	59.93	58.77	59.48	59.98	59.83
Fixed Assets
Gross Block	0.31	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	0.29	0	0	0	0	0	0	0	0	0
Net Fixed Assetsⓘ	0.02	0	0	0	0	0	0	0	0	0
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	43.67	54	43.14	53.78	54.03	53.13	52.26	52.26	54.18	45.56
Inventories	0	0	0	0	0	0	0	0	0	0
Trade Receivables	8.16	0.43	12.58	0	0	0.92	0.92	1.68	1.05	0
Cash Equivalents	0.26	0.27	0.34	0.34	0.33	0.30	0.28	0.23	0.04	0
Others Assetsⓘ	8.01	4.84	2.98	4.84	5.57	5.57	5.31	5.31	4.71	14.27
Total Assets ⓘ	60.12	59.54	59.03	58.97	59.94	59.93	58.77	59.48	59.98	59.83

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	3.89	8.27	-10.90	10.66	-0.85	-0.93	0.17	-0.11	4.90	-0.40
PBT ⓘ	-0.08	-0.07	-0.13	-0.08	-0.06	-0.01	-0.09	0	0.13	-1.33
Adjustment ⓘ	0.01	0	0	0	0	0	0	0	0	0
Changes in Working Capital ⓘ	3.96	8.34	-10.77	10.73	-0.78	-0.92	0.26	-0.11	4.8	0.89
Tax Paid ⓘ	0	0	0	0	0	0	0	0	-0.04	0.04
Cash Flow From Investing Activity ⓘ	-4.45	-10.31	10.86	-10.65	-0.25	0.90	0.88	0	-5.01	0
Capex	0	0.02	0	0	0	0	0	0	0	0
Net Investments	-4.45	-10.33	10.86	-10.65	-0.25	0.90	0.88	0	-1.92	0
Others ⓘ	0	0	0	0	0	0	0	0	-3.09	0
Cash Flow From Financing Activityⓘ	0.56	2.05	0.10	0	1.09	0	-1.07	0.06	-0.08	0.36
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.56	2.05	0.10	0	1.09	0	-1.07	0.06	-0.08	0.36
Net Cash Flow ⓘ	0	0.01	0.06	0.01	-0.01	-0.03	-0.03	-0.05	-0.19	-0.04

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	-0.14	-0.13	-0.21	-0.13	-0.11	-0.02	-0.16	0	0.17	-2.24
ROCE (%)	-0.14	-0.12	-0.21	-0.05	-0.11	-0.02	-0.15	0	0.23	-2.26
Asset Turnover Ratio	29.99	0	0	0	0	0.02	0	0.01	0.05	0.04
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	49	N/A
Working Capital Days
Receivable Days	2	0	0	0	0	365	0	624	153	0
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0	183	0	0

Johnson Pharmacare Ltd Stock News

Johnson Pharmacare Ltd FAQs

What is the share price of Johnson Pharmacare?

Company share prices are keep on changing according to the market conditions. The closing price of Johnson Pharmacare on 19-Apr-2024 16:01 is ₹0.79.

What is the market cap of Johnson Pharmacare?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 19-Apr-2024 16:01 the market cap of Johnson Pharmacare stood at ₹44.00.

What is the P/E ratio of Johnson Pharmacare?

The latest P/E ratio of Johnson Pharmacare as of 19-Apr-2024 16:01 is 0.00.

What is the P/B ratio of Johnson Pharmacare?

The latest P/B ratio of Johnson Pharmacare as of 19-Apr-2024 16:01 is 0.78.

What is the 52-week high and low of Johnson Pharmacare?

The 52-week high of Johnson Pharmacare is ₹1.38 and the 52-week low is ₹0.45.

What is the TTM revenue of Johnson Pharmacare?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Johnson Pharmacare is ₹0.00 ( Cr.) .

About Johnson Pharmacare Ltd

Johnson Pharmacare Limited (formerly known as Robinson Worldwide Trade Limited) is a listed public company incorporated on June 30, 1994. It is classified as a public limited company and is located in Ahmedabad, Gujarat.

The company went for public issue on February 20, 1997. The company has changed its name from Robinson Worldwide Trade Ltd. to Sun & Shine Worldwide Ltd. in 2011 and in 2021 the name has been changed to Johnson Pharmacare Limited.

Business area of the company

Initially the company was involved in trading business with objectives to provide business services. As of now the Company is not engaged in any activity and the management is looking for a right opportunity to make the Company operational.